Antimicrobial-resistant Bacteroides fragilis in Thailand and their inhibitory effect in vitro on the growth of Clostridioides difficile

Imwattana, K., Kiratisin, P. and Riley, T.V. (2022) Antimicrobial-resistant Bacteroides fragilis in Thailand and their inhibitory effect in vitro on the growth of Clostridioides difficile. Anaerobe, 73 . Art. 102505.

Abstract

Objectives

The aim of this study was to investigate antimicrobial-resistant Bacteroides fragilis in Thailand and possible effects of such strains on human health and disease.

Methods

Phenotypic antimicrobial susceptibility testing was performed on 17 clinical B. fragilis isolates. The genome of one isolate was sequenced and analysed to explore its resistance genotype. An in vitro growth assay was conducted to evaluate the inhibitory effect of B. fragilis on Clostridioides difficile.

Results

There was a high prevalence of clindamycin (71%), meropenem (47%) and moxifloxacin (29%) resistance. Most strains remained susceptible to metronidazole, but one had high-level metronidazole resistance conferred by a nimD-containing plasmid. B. fragilis displayed an in vitro inhibitory effect on the growth of C. difficile and a drug-resistant strain retained this inhibition in the presence of clindamycin.

Conclusions

Antimicrobial resistance was seen in Thai B. fragils isolates, which may help protect the host against C. difficile infection.

Item Type:	Journal Article
Murdoch Affiliation(s):	Medical, Molecular and Forensic Sciences
Publisher:	Academic Press
Copyright:	© 2022 Elsevier Ltd.
URI:	http://researchrepository.murdoch.edu.au/id/eprint/63477

Item Control Page